AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 11

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.93 % area, n=455. Read the 2026-Q3 state-of-the-index report →

455 records12 pagesmedian on this page 99.03 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041929IGF-1 LR3SinoPepSNP-2606-D4620PeptideMeter2026-Q398.495.35104.1Buyer-sourced0PASS
AX-2026-041605CJC-1295 (no DAC)QSCQSC-2606-V7416PeptideMeter2026-Q397.963.59102.5Laboratory-retained1FAIL
AX-2026-043473CJC-1295 with DACBCHBCH-2607-H5235Janoshik2026-Q397.476.1795.6Buyer-sourced1FAIL
AX-2026-043181Kisspeptin-10GL BiochemGLBI-2608-N7715Janoshik2026-Q398.774.0695.2Buyer-sourced1MARGINAL
AX-2026-042600SemaglutideHJHJ-2608-C7002Janoshik2026-Q399.203.61—Buyer-sourced0PASS
AX-2026-042599SemaglutideHJHJ-2608-C7002Medutest2026-Q399.933.2397.1Buyer-sourced1MARGINAL
AX-2026-042529GHRP-6HJHJ-2603-R5329Janoshik2026-Q399.572.45—Buyer-sourced0PASS
AX-2026-042089MOTS-cHYBHYB-2606-D7858Medutest2026-Q399.382.65—Buyer-sourced0PASS
AX-2026-042018GHRP-6AMBAMB-2603-S5667Medutest2026-Q399.566.5798.3Buyer-sourced1FAIL
AX-2026-041378IpamorelinQYBQYB-2605-H3558Janoshik2026-Q399.813.97—Buyer-sourced0PASS
AX-2026-042759Melanotan IIGGPepsGGPE-2603-P1474Janoshik2026-Q399.156.71105.1Buyer-sourced0PASS
AX-2026-042014GHRP-6AMBAMB-2603-S5667PeptideMeter2026-Q399.246.62—Buyer-sourced0PASS
AX-2026-041792RetatrutideASYASY-{CAT}-2288Kestrel2026-Q399.826.81—Buyer-sourced0PASS
AX-2026-043349LeuprolideWXTWXT-2604-K2596VendorInvestigate2026-Q398.645.23105.1Buyer-sourced0PASS
AX-2026-042643SemaglutideSWBSWB-2602-X7905Nordanalyt2026-Q398.773.9892.7Buyer-sourced0PASS
AX-2026-042515SemaxHomopeptideHOMO-2605-S5227Janoshik2026-Q399.935.5297.9Buyer-sourced0PASS
AX-2026-042125TB-500JEEPJEEP-2602-V8614VendorInvestigate2026-Q399.883.72—Buyer-sourced1MARGINAL
AX-2026-041908IpamorelinSinoPepSNP-2606-L4478Janoshik2026-Q399.475.4295.3Supplier-supplied0PASS
AX-2026-041892IpamorelinSinoPepSNP-2602-B3833Nordanalyt2026-Q399.735.3588.9Buyer-sourced2MARGINAL
AX-2026-041775TB-500ASYASY-{CAT}-2167Janoshik2026-Q399.933.9899.6Buyer-sourced1FAIL
AX-2026-041470PT-141 (Bremelanotide)QYBQYB-2607-L4875Janoshik2026-Q399.774.10—Buyer-sourced0PASS
AX-2026-043441BPC-157BCHBCH-2603-G4350Janoshik2026-Q398.434.73103.7Buyer-sourced1MARGINAL
AX-2026-042221SS-31 (Elamipretide)TFCTFC-2607-R9099PeptideMeter2026-Q399.464.55101.1Buyer-sourced0PASS
AX-2026-041781TB-500ASYASY-{CAT}-2167Medutest2026-Q399.884.4197.4Buyer-sourced1FAIL
AX-2026-043444BPC-157BCHBCH-2603-G4350Medutest2026-Q398.075.05104.6Buyer-sourced1MARGINAL
AX-2026-043344LeuprolideWXTWXT-2604-K2596Janoshik2026-Q398.585.34—Buyer-sourced0PASS
AX-2026-042604SemaglutideHJHJ-2608-C7002Janoshik2026-Q399.124.19102.5Buyer-sourced0PASS
AX-2026-042082MOTS-cHYBHYB-2606-D7858Janoshik2026-Q399.862.13—Buyer-sourced0PASS
AX-2026-043472CJC-1295 with DACBCHBCH-2607-H5235PeptideMeter2026-Q397.585.93—Laboratory-retained1MARGINAL
AX-2026-043279TirzepatideCPCCPC-2607-L1516Janoshik2026-Q396.575.8292.0Buyer-sourced0FAIL
AX-2026-043258L-CarnosineCPCCPC-2603-G9615Medutest2026-Q398.9510.1597.8Buyer-sourced0FAIL
AX-2026-042490SS-31 (Elamipretide)HomopeptideHOMO-2604-D5484Medutest2026-Q399.753.11—Buyer-sourced0PASS
AX-2026-042472LL-37HomopeptideHOMO-2602-G5165Nordanalyt2026-Q398.755.17—Buyer-sourced0PASS
AX-2026-043375SemaglutideWXTWXT-2604-C3248PeptideMeter2026-Q397.694.0495.1Supplier-supplied1MARGINAL
AX-2026-043180Kisspeptin-10GL BiochemGLBI-2608-N7715Janoshik2026-Q398.693.9988.8Buyer-sourced2MARGINAL
AX-2026-042253TirzepatideTFCTFC-2605-G9870PeptideMeter2026-Q398.196.4193.7Supplier-supplied0PASS
AX-2026-041928IGF-1 LR3SinoPepSNP-2606-D4620Janoshik2026-Q398.165.20105.7Supplier-supplied0PASS
AX-2026-043533GHRP-2SIGSIG-2603-6031Janoshik2026-Q398.511.1392.1Buyer-sourced0FAIL
AX-2026-042238Humanin (HNG)TFCTFC-2608-S9940Janoshik2026-Q398.331.9296.5Buyer-sourced0PASS
AX-2026-042080MOTS-cHYBHYB-2606-D7858VendorInvestigate2026-Q398.292.1095.6Laboratory-retained0PASS